| Identification | |
| Name: | Evodiamine |
| Synonyms: | Evodiamine(6CI,7CI,8CI);Indolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one,8,13,13b,14-tetrahydro-14-methyl-, (S)-;(+)-Evodiamine;Evodiamine, (+)-;d-Evodiamine;Indolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one,8,13,13b,14-tetrahydro-14-methyl-, (13bS)-; |
| CAS: | 518-17-2 |
| Molecular Formula: | C19H17N3O |
| Molecular Weight: | 303.36 |
| InChI: | InChI=1/C19H17N3O/c1-21-16-9-5-3-7-14(16)19(23)22-11-10-13-12-6-2-4-8-15(12)20-17(13)18(21)22/h2-9,18,20H,10-11H2,1H3 |
| Molecular Structure: | ![(C19H17N3O) Evodiamine(6CI,7CI,8CI);Indolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one,8,13,13b,14-tetrahydro-14...](https://img.guidechem.com/casimg/518-17-2.gif) |
| Properties | |
| Transport: | UN 2811 6.1/PG 3 |
| Melting Point: | 263 - 265 |
| Density: | 1.39 g/cm3 |
| Refractive index: | 1.764 |
| Solubility: | Insoluble |
| Appearance: | Fine Powder Color |
| Specification: |
? Evodiamine (CAS NO.518-17-2), its Synonyms are (+)-Evodiamine ; Evodiamine, (+)- ; d-Evodiamine ; Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (13bS)- ; Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (S)- . |
| Usage: | Has been shown to reduce fat uptake in mouse studies. |
| Safety Data | |
 |
|
